Sensome Raises €4.6 Million to Bring the First Connected Stroke Device to Market
https://www.businesswire.com/news/home/20180610005022/en/
PARIS--(BUSINESS WIRE)--Jun 11, 2018--Sensome, the company pioneering the connected medical device revolution with the world’s smallest sensor to identify biological tissues, announced today the successful completion of a new 4.6 million euro financing round to bring the Clotild™ smart stroke guidewire to market. Kurma Partners led the existing venture capital syndicate (Paris-Saclay Seed Fund, Idinvest) and other historical investors and was joined by venture capital firm BNP Paribas Développement.
The company’s sensing technology combines impedance-based micro-sensors with machine learning algorithms to instantly identify biological tissues with an unequaled predictive reliability. The sensors are so thin that they can be seamlessly integrated with any medical device.